Yu-Lin Lin results 28
· Newest (Page 1/2, per page 25)
Search Results
Prospective study of an adalimumab combined with partial enteral nutrition in the induction period of Crohn’s diseaseNARA Subscribed
Background Adalimumab monotherapy can suppress gut inflammation and induce remission in active Crohn’s disease but has some limitations. Exclusive enteral nutrition (EEN) is recommended for patients with mild to moderate Crohn’s disease (CD), but implementation is challenging. Aim To evaluate the effectiveness of adalimumab combined with partial enteral nutrition (PEN) in the induction therapy for Crohn’s disease. Methods A pr...